Innoture's IP allows freedom to operate within the crowded microneedle landscape and offers a truly adaptive, tailored, application optimised solution.

Research and development is based at the state-of-the-art institute of Life Science Swansea University and there is a knowledge transfer partnership in place with the Biocomposites Centre at Bangor University. The company is backed by a range of notable investors from the pharmaceutical industry.